HomeWXIBF • OTCMKTS
WuXi Biologics (Cayman) Inc
$2.50
Okt 23, 12:20:57 AM GMT-4 · USD · OTCMKTS · Disclaimer
StockSegurong nakalista sa US
Nakaraang pagsara
$2.50
Sakop ng taon
$1.30 - $6.60
Market cap
70.05B HKD
Average na Volume
311.00
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
CDP Climate Change Score
A-
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
(CNY)Hun 2024Y/Y na pagbabago
Kita
4.29B0.97%
Gastos sa pagpapatakbo
765.14M21.62%
Net na kita
749.54M-33.86%
Net profit margin
17.48-34.51%
Kita sa bawat share
EBITDA
1.24B-13.32%
Aktuwal na % ng binabayarang buwis
11.36%
Kabuuang asset
Kabuuang sagutin
(CNY)Hun 2024Y/Y na pagbabago
Cash at mga panandaliang investment
9.53B9.60%
Kabuuang asset
56.11B7.60%
Kabuuang sagutin
11.46B-12.46%
Kabuuang equity
44.64B
Natitirang share
4.15B
Presyo para makapag-book
0.26
Return on assets
4.05%
Return on capital
4.62%
Net change in cash
(CNY)Hun 2024Y/Y na pagbabago
Net na kita
749.54M-33.86%
Cash mula sa mga operasyon
651.06M-52.65%
Cash mula sa pag-invest
-191.26M75.93%
Cash mula sa financing
-737.79M-684.70%
Net change in cash
-258.16M-153.79%
Malayang cash flow
350.65M52.56%
Tungkol
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development. WuXi Biologics' roots date back to 2010, and began building out capabilities and facilities required for biologics discovery, development and GMP manufacturing. WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017. As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore. In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong. In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
Itinatag
2010
Mga Empleyado
12,435
Tumuklas pa
Maaaring interesado ka sa
Nabuo ang listahang ito mula sa mga paghahanap kamakailan lang, mga sinubaybayang security, at iba pang aktibidad. Alamin pa

“As is” na ibinibigay ang lahat ng data para lang sa mga layunin sa personal na impormasyon, at hindi inilaan na maging payong pinansyal, ni hindi rin ito para sa mga layunin sa trading o investment, buwis, legal, accounting, o iba pang payo. Hindi tagapayo sa investment ang Google, ni hindi rin ito pinansyal na tagapayo at walang inihahayag na pananaw, rekomendasyon, o opinyon patungkol sa anumang kumpanyang kasama sa listahang ito o sa anumang seguridad na inisyu ng mga kumpanyang iyon. Konsultahin ang iyong broker o pampinansyal na kinatawan para ma-verify ang presyo bago magsagawa ng anumang trade. Matuto pa
Naghanap din ang mga tao ng
Search
I-clear ang paghahanap
Isara ang paghahanap
Mga app ng Google
Pangunahing menu